2 recruiting, 1 completed. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Recruiting 2, Completed 1 |
Follow Cystic Fibrosis (CF): new trials by email Literature Review of Cystic Fibrosis (CF) trials Research Report on Cystic Fibrosis (CF)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Elexacaftor, Tezacaftor, Ivacaftor, Ivacaftor (VX-770) - Cystic Fibrosis (CF) | Phase 4 | Recruiting | Istituto Giannina Gaslini | 50 | 2026-09-18 | 2026-10-14 |
| Ensuring Access to Optimal Therapy in CF: The ENACT Study Elexacaftor / Ivacaftor / Tezacaftor, therapeutic drug monitoring - Cystic Fibrosis (CF) | Phase 4 | Recruiting | Arkansas Children's Hospital Research Institute | 100 | 2025-06-10 | 2026-06-02 |
| Safety of Stopping Pancreatic Enzyme Replacement Therapy in Children With Improved Pancreatic Function After Highly Effective Modulator Therapy Discontinuation of Pancreatic Enzyme Replacement Therapy - Cystic Fibrosis (CF), Pancreatic Insufficiency | Phase 4 | Completed | Indiana University | 17 | 2024-12-03 | 2026-07-02 |
Cystic Fibrosis (3) · Exocrine Pancreatic Insufficiency (1) · Pancreatic Diseases (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Digestive System Diseases (3) · Genetic Diseases, Inborn (3) · Infant, Newborn, Diseases (3) · Lung Diseases (3) · Respiratory Tract Diseases (3) · Pancreatic Diseases (2)
elexacaftor, ivacaftor, tezacaftor drug combination (2) · ivacaftor (1) · tezacaftor, ivacaftor drug combination (1)
Arkansas Children's Hospital Research Institute (1) · Indiana University (1) · Istituto Giannina Gaslini (1)
United States (2) · Italy (1)
Jennifer S Guimbellot, Medical Degree and License (1)
R01HL171034 (1)